The Three Reasons Life Sciences Companies Miss Revenue Targets (And How to Fix Them)

After working with dozens of Life Sciences organizations, the same three root causes appear again and again when revenue targets are missed. Understanding them is the first step to fixing them.

Pattern Recognition in Commercial Failure

After more than a decade of working with Life Sciences companies — from pre-launch startups to established commercial organizations — certain patterns emerge when revenue targets are missed.

The symptoms vary. The pipeline is thin. The sales cycle is longer than projected. Reps are churning. Deals are stalling at the same stage. Customers are interested but not converting.

But beneath these symptoms, the root causes almost always fall into one of three categories.

Root Cause #1: Misaligned Positioning

The most common cause of missed revenue targets is a positioning problem — the company is communicating value in a way that doesn't match what customers actually care about.

This often happens because positioning was developed internally, based on what the product team and leadership believe is most important, rather than what customers have told them is most important.

The result is a sales team that's having the wrong conversation. They're leading with clinical outcomes when the customer is primarily concerned with workflow integration. Or they're emphasizing cost savings when the customer's primary concern is reimbursement risk.

The fix: A structured Voice of Customer process to validate (or correct) your positioning before you invest further in sales execution.

Root Cause #2: Wrong Target Market

The second most common cause is targeting the wrong segment first. Not all potential customers are equally ready to buy your product, and launching into the wrong segment wastes time, money, and credibility.

Early-stage companies are particularly vulnerable to this. Eager to demonstrate traction, they pursue the largest or most prestigious accounts — which often have the longest sales cycles, the most complex procurement processes, and the least tolerance for unproven products.

Meanwhile, the Early Adopters who would buy quickly, provide valuable feedback, and serve as references are being ignored.

The fix: A rigorous market segmentation analysis that identifies not just who *could* buy your product, but who is *most likely* to buy it *first* — and why.

Root Cause #3: Broken Sales Process

The third root cause is a sales process that doesn't match the actual buying process of your customers.

This manifests in several ways: deals stalling at the same stage, inconsistent messaging across the sales team, inability to accurately forecast, and high rep turnover driven by frustration with a process that doesn't work.

The underlying issue is usually that the sales process was designed in a conference room rather than derived from observation of how customers actually make decisions. It doesn't account for the real stakeholders, the real objections, or the real timeline.

The fix: A sales process audit that maps your current process against the actual customer journey — and identifies the specific gaps that are causing deals to stall or fall through.

Why These Three?

These three root causes are so common because they all stem from the same underlying problem: commercial strategy built on assumptions rather than validated data.

The good news is that all three are diagnosable and fixable. The bad news is that fixing them requires honest assessment — which is often easier with an outside perspective than from within the organization.

*If your organization is experiencing any of these symptoms, Monona Technical Resources can help you diagnose the root cause and develop a corrective strategy. Contact us to start the conversation.*